File:Thalidomide - limb signaling.jpg: Difference between revisions

Revision as of 14:03, 7 October 2014

Changes in limb signaling events occur secondary to vascular inhibition

CPS49 - a tetrafluorinated analogue of thalidomide that is chemically and structurally related to thalidomide breakdown products.

A – P - HH St18 embryos treated with DMSO or CPS49 and fixed 3 h, 6 h, or 24 h later. Stained for cell death or by wholemount in situ hybridisation
A – F - stained for cell death
G – I - Fgf8 expression
J – L - Fgf10 expression
M and N - Bmp4 expression
O and P - HIF-1 expression

untreated limb to left (G–P). (E and F)

Arrows indicate increased cell death in CPS49-treated limbs.

(H and I) Arrowheads indicate decreased Fgf8 expression relative to the contralateral limb, which serves as an internal control.

There is no significant difference in numbers of proliferating cells in CPS49-treated limbs as compared with control limbs.

Scale bars: A–F, 500 μm; G–I, 400 μm; Q–S, 250 μm

Links:

Reference

Copyright

Proceedings National Academy of Sciences (PNAS) Liberalization of PNAS copyright policy: Noncommercial use freely allowed Note original Author should be contacted for permission to reuse for Educational purposes. See also PNAS Author Rights and Permission FAQs

Cozzarelli NR, Fulton KR, Sullenberger DM. Liberalization of PNAS copyright policy: noncommercial use freely allowed. Proc Natl Acad Sci U S A. 2004 Aug 24;101(34):12399. PMID15314225 "Our guiding principle is that, while PNAS retains copyright, anyone can make noncommercial use of work in PNAS without asking our permission, provided that the original source is cited."

Help:Copyright Tutorial

Modified from Fig. 2. A-L http://www.pnas.org/content/106/21/8573/F2.expansion.html

File history

Yi efo/eka'e gwa ebo wo le nyangagi wuncin ye kamina wunga tinya nan

	Gwalagizhi	Nyangagi	Dimensions	User	Comment
current	16:34, 17 June 2010		628 × 540 (88 KB)	S8600021 (talk \| contribs)	==Changes in limb signaling events occur secondary to vascular inhibition<ref><pubmed>19433787</pubmed></ref>== CPS49 - a tetrafluorinated analogue of thalidomide that is chemically and structurally related to thalidomide breakdown products. (A–P) HH

You cannot overwrite this file.

File usage

The following page uses this file:

Abnormal Development - Thalidomide

@@ Line 1: / Line 1: @@
-==Changes in limb signaling events occur secondary to vascular inhibition<ref><pubmed>19433787</pubmed></ref>==
+==Changes in limb signaling events occur secondary to vascular inhibition==
 CPS49 - a tetrafluorinated analogue of thalidomide that is chemically and structurally related to thalidomide breakdown products.
-(A–P) HH St18 embryos treated with DMSO or CPS49 and fixed 3 h, 6 h, or 24 h later. Stained for cell death or by wholemount in situ hybridization
+* '''A – P''' - HH St18 embryos treated with DMSO or CPS49 and fixed 3 h, 6 h, or 24 h later. Stained for cell death or by wholemount in situ hybridisation
+* '''A – F''' - stained for cell death
-(A–F) - stained for cell death
+* '''G – I'''  -  Fgf8  expression
+* '''J – L''' - Fgf10 expression
-(G–I) -  Fgf8  expression
+* '''M and N''' - Bmp4 expression
+* '''O and P''' - HIF-1 expression
-(J–L) - Fgf10 expression
-(M and N) - Bmp4 expression
-(O and P) - HIF-1 expression
 untreated limb to left (G–P). (E and F)
@@ Line 23: / Line 18: @@
 There is no significant difference in numbers of proliferating cells in CPS49-treated limbs as compared with control limbs.
-(Scale bars: A–F, 500 μm; G–I, 400 μm; Q–S, 250 μm.)
+Scale bars: A–F, 500 μm; G–I, 400 μm; Q–S, 250 μm
+:'''Links:'''
+===Reference===
+<pubmed>19433787</pubmed>
-Modified from Fig. 2. A-L http://www.pnas.org/content/106/21/8573/F2.expansion.html
-==Reference==
-<references/>
+{{PNAS}}
-{{Template:PNAS}}
+Modified from Fig. 2. A-L http://www.pnas.org/content/106/21/8573/F2.expansion.html
 [[Category:Abnormal Development]] [[Category:Chicken]] [[Category:Limb]] [[Category:Cardiovascular]] [[Category:Teratogen]] [[Category:FGF]]